Category: Latest News
-
U.S. Payrolls Fall Unexpectedly, Signalling Weakness in the Labour Market
The latest U.S. Nonfarm Payrolls report delivered an unexpected setback, with employment declining instead of posting the job growth economists had anticipated. The figures have raised fresh concerns about the strength of the U.S. economy and the outlook for the labour market. According to the report, nonfarm payrolls fell by 23,000 jobs in July, compared…
-
U.S. Stocks Poised for Higher Open as Weak Jobs Report Boosts Rate Cut Hopes: Dow Jones, S&P, Nasdaq, Wall Street Futures
U.S. stock futures pointed to a stronger open on Friday after a weaker-than-expected July employment report eased concerns that the Federal Reserve could raise interest rates again in the near term. Futures accelerated higher following the release of the latest Labor Department data, with investors interpreting the softer labour market figures as reducing the likelihood…
-
Century Casinos Shares Rise Despite Second-Quarter Earnings Miss
Century Casinos, Inc. (NASDAQ:CNTY) reported second-quarter 2026 results that fell short of Wall Street expectations, but shares rose around 4.2% in premarket trading as investors focused on the company’s improving performance across its North American operations. Although earnings and revenue came in below forecasts, stronger profitability at key US properties helped offset weakness in other…
-
Docebo Beats Earnings Expectations and Raises Full-Year Outlook
Docebo Inc. (NASDAQ:DCBO) reported second-quarter 2026 results that exceeded profit forecasts but came in slightly below revenue expectations. Despite the mixed quarterly performance, the learning management platform provider raised its full-year guidance, helping shares edge modestly higher in premarket trading. Earnings Outperform Despite Revenue Miss Docebo posted adjusted earnings of $0.35 per share, beating analysts’…
-
Guardian Pharmacy Services Raises 2026 Outlook After Strong Second Quarter
Guardian Pharmacy Services, Inc. (NYSE:GRDN) reported second-quarter 2026 results and increased its financial guidance for the full year, sending shares up around 3.2% in premarket trading. The long-term care pharmacy provider pointed to continued operational momentum despite revenue growth being affected by pricing changes linked to the Inflation Reduction Act (IRA). Revenue Grows as Company…
-
Savers Value Village Meets Second-Quarter Expectations and Improves Sales Outlook
Savers Value Village, Inc. (NYSE:SVV) reported second-quarter 2026 results that were broadly in line with Wall Street expectations, while raising its comparable store sales outlook for the full year. The thrift retailer also highlighted continued momentum in profitability and new store performance. Shares were little changed in premarket trading following the earnings announcement. Revenue and…
-
Claritev Beats Second-Quarter Expectations and Raises Full-Year Guidance
Claritev Corporation (NYSE:CTEV) reported second-quarter 2026 results that surpassed Wall Street expectations, driven by solid revenue growth and stronger-than-anticipated earnings. The healthcare technology company also increased its financial guidance for the full year, reflecting confidence in its operating performance. Despite the earnings beat, the stock was little changed in after-hours trading following the announcement. Revenue…
-
Figs Shares Jump After Strong Second-Quarter Results and Higher 2026 Outlook
Figs (NYSE:FIGS) shares surged 27.7% in premarket trading after the healthcare apparel company reported second-quarter 2026 results that comfortably exceeded Wall Street expectations. Strong earnings, accelerating revenue growth and improved profitability prompted management to raise its outlook for the full year and expand its share repurchase programme. The results reinforced investor confidence that the company…
-
Doximity Shares Soar After Revenue Beat and Higher Full-Year Forecast
Doximity (NYSE:DOCS) shares surged 66% in premarket trading after the digital healthcare platform reported fiscal first-quarter 2027 results that exceeded revenue expectations and prompted management to raise its outlook for the full financial year. The strong performance, combined with growing momentum in the company’s artificial intelligence offerings, helped reverse negative sentiment that had weighed on…
-
ResMed Shares Fall After Revenue Miss and Conservative 2027 Outlook
ResMed (NYSE:RMD) shares declined 5.5% in premarket trading after the medical device manufacturer reported fourth-quarter fiscal 2026 results that delivered an earnings beat but fell slightly short on revenue. Investors were also disappointed by the company’s first full-year financial outlook, which pointed to slower growth in fiscal 2027. While profitability exceeded expectations, a softer revenue…